Robert W. Baird Forecasts Strong Price Appreciation for AdaptHealth (NASDAQ:AHCO) Stock

AdaptHealth (NASDAQ:AHCO - Get Free Report) had its price target lifted by equities researchers at Robert W. Baird from $14.00 to $16.00 in a report released on Thursday,Benzinga reports. The firm presently has an "outperform" rating on the stock. Robert W. Baird's target price would indicate a potential upside of 45.45% from the company's current price.

A number of other equities analysts also recently commented on the stock. Canaccord Genuity Group raised their price objective on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a "buy" rating in a report on Wednesday, February 26th. Royal Bank of Canada increased their target price on shares of AdaptHealth from $11.00 to $14.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 26th. UBS Group lowered their target price on AdaptHealth from $12.00 to $11.00 and set a "buy" rating for the company in a research note on Thursday, February 13th. Finally, Truist Financial boosted their target price on shares of AdaptHealth from $12.00 to $14.00 and gave the stock a "buy" rating in a research note on Wednesday, February 26th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, AdaptHealth presently has an average rating of "Buy" and a consensus target price of $13.80.

AdaptHealth Stock Performance

Shares of NASDAQ AHCO traded down $0.38 during trading hours on Thursday, reaching $11.00. The stock had a trading volume of 1,859,263 shares, compared to its average volume of 1,092,632. AdaptHealth has a twelve month low of $8.35 and a twelve month high of $11.90. The company has a debt-to-equity ratio of 1.34, a current ratio of 1.24 and a quick ratio of 1.00. The business's fifty day moving average is $9.92 and its two-hundred day moving average is $10.24. The company has a market cap of $1.48 billion, a price-to-earnings ratio of -6.67, a PEG ratio of 1.08 and a beta of 1.12.

Hedge Funds Weigh In On AdaptHealth

Several hedge funds have recently added to or reduced their stakes in the stock. Mackenzie Financial Corp raised its position in shares of AdaptHealth by 111.8% in the 4th quarter. Mackenzie Financial Corp now owns 81,583 shares of the company's stock valued at $777,000 after acquiring an additional 43,059 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in AdaptHealth by 21.8% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 197,901 shares of the company's stock valued at $1,884,000 after purchasing an additional 35,431 shares in the last quarter. State of Wyoming increased its position in shares of AdaptHealth by 26.5% in the fourth quarter. State of Wyoming now owns 30,641 shares of the company's stock valued at $292,000 after acquiring an additional 6,418 shares during the last quarter. ProShare Advisors LLC raised its stake in shares of AdaptHealth by 44.3% during the 4th quarter. ProShare Advisors LLC now owns 30,766 shares of the company's stock worth $293,000 after purchasing an additional 9,450 shares in the last quarter. Finally, Nuveen Asset Management LLC raised its position in AdaptHealth by 27.9% during the fourth quarter. Nuveen Asset Management LLC now owns 316,108 shares of the company's stock worth $3,009,000 after acquiring an additional 69,050 shares in the last quarter. Institutional investors and hedge funds own 82.67% of the company's stock.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.